Acquired hemophilia A (AHA) is a rare, but often severe, bleeding disorder caused by
autoantibodies against clotting factor VIII (FVIII). AHA occurs more frequently in the elderly …

Acquired hemophilia A is a rare bleeding disorder caused by autoantibodies to coagulation
FVIII. Bleeding episodes at presentation are spontaneous and severe in most cases. Optimal …

Acquired hemophilia A (AHA) is an autoimmune disease caused by an autoantibody to
factor VIII. Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated …

Acquired hemophilia A is a rare, autoimmune disorder that is caused by autoantibodies that
act as inhibitors to factor VIII. It is characterized by severe, unexpected bleeding that may be …

Please cite this paper as: Tengborn L, Baudo F, Huth‐Kühne A, Knoebl P, Lévesque H,
Marco P, Pellegrini F, Nemes L, Collins P on behalf of the EACH2 registry contributors …

Management of acquired hemophilia A is challenging and should be undertaken in close
collaboration with a hemophilia center with expertise in the field. Treatment involves …

Objectives: In acquired hemophilia (AH), autoantibodies (inhibitors) impede blood
coagulation factors leading to severe bleedings. Cornerstones of a successful treatment are …

Background: Acquired hemophilia A (AHA) is a severe life‐threatening autoimmune disease
due to the development of autoantibodies that neutralize the procoagulant activity of factor …

Acquired haemophilia is a potentially life-threatening bleeding disorder. Its early diagnosis
and treatment is of major importance. We evaluated the elapsed time between the first …

Résumé Introduction L'hémophilie A acquise (HA) est une maladie hémorragique rare
secondaire à l'apparition d'un auto-anticorps dirigé contre le facteur VIII. Chez le sujet jeune …